Differential Expression of Three T Lymphocyte-activating CXC Chemokines by Human Atheroma-associated Cells

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1999 Oct 19

PMID 10525042

Citations 117

Authors

F Mach

A Sauty

A S Iarossi

G K Sukhova

K Neote

P Libby

A D Luster

Affiliations

Soon will be listed here.

Abstract

Activated T lymphocytes accumulate early in atheroma formation and persist at sites of lesion growth and rupture, suggesting that they may play an important role in the pathogenesis of atherosclerosis. Moreover, atherosclerotic lesions contain the Th1-type cytokine IFN-gamma, a potentiator of atherosclerosis. The present study demonstrates the differential expression of the 3 IFN-gamma-inducible CXC chemokines--IFN-inducible protein 10 (IP-10), monokine induced by IFN-gamma (Mig), and IFN-inducible T-cell alpha chemoattractant (I-TAC)--by atheroma-associated cells, as well as the expression of their receptor, CXCR3, by all T lymphocytes within human atherosclerotic lesions in situ. Atheroma-associated endothelial cells (ECs), smooth muscle cells (SMCs), and macrophages (MO) all expressed IP-10, whereas Mig and I-TAC were mainly expressed in ECs and MO, as detected by double immunofluorescence staining. ECs of microvessels within lesions also expressed abundant I-TAC. In vitro experiments supported these results and showed that IL-1beta, TNF-alpha, and CD40 ligand potentiated IP-10 expression from IFN-gamma-stimulated ECs. In addition, nitric oxide (NO) treatment decreased IFN-gamma induction of IP-10. Our findings suggest that the differential expression of IP-10, Mig, and I-TAC by atheroma-associated cells plays a role in the recruitment and retention of activated T lymphocytes observed within vascular wall lesions during atherogenesis.

Citing Articles

CXCR3-CXCL11 Signaling Restricts Angiogenesis and Promotes Pericyte Recruitment.

Lee J, Goeckel M, Levitas A, Colijn S, Shin J, Hindes A Arterioscler Thromb Vasc Biol. 2024; 44(12):2577-2595.

PMID: 39360413 PMC: 11594002. DOI: 10.1161/ATVBAHA.124.321434.

Endothelial cell Notch signaling programs cancer-associated fibroblasts to promote tumor immune evasion.

Zhu Y, Xiang M, Brulois K, Lazarus N, Pan J, Butcher E Res Sq. 2024; .

PMID: 38947054 PMC: 11213189. DOI: 10.21203/rs.3.rs-4538031/v1.

The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease.

Zhang H, Dhalla N Int J Mol Sci. 2024; 25(2).

PMID: 38256155 PMC: 10817020. DOI: 10.3390/ijms25021082.

CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients.

Shamsi A, Roghani S, Abdan Z, Soufivand P, Pournazari M, Bahrehmand F Inflammation. 2023; 46(6):2374-2385.

PMID: 37542661 DOI: 10.1007/s10753-023-01884-5.

Synthesis and preclinical evaluation of a novel fluorine-18 labeled small-molecule PET radiotracer for imaging of CXCR3 receptor in mouse models of atherosclerosis.

Alluri S, Higashi Y, Berendzen A, Grisanti L, Watkinson L, Singh K EJNMMI Res. 2023; 13(1):67.

PMID: 37438543 PMC: 10338423. DOI: 10.1186/s13550-023-01017-x.

References

Gimbrone Jr M, COTRAN R, Folkman J . Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol. 1974; 60(3):673-84. PMC: 2109230. DOI: 10.1083/jcb.60.3.673. View

Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. DOI: 10.1056/NEJM199901143400207. View

Kouretas P, Kim Y, Cahill P, Myers A, To L, Wang Y . Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog. Circulation. 1999; 99(8):1062-8. DOI: 10.1161/01.cir.99.8.1062. View

Wang B, Ho H, Lin P, Schwarzacher S, Pollman M, Gibbons G . Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation. 1999; 99(9):1236-41. DOI: 10.1161/01.cir.99.9.1236. View

Sauty A, Dziejman M, Taha R, Iarossi A, Neote K, Garcia-Zepeda E . The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol. 1999; 162(6):3549-58. View

Loetscher M, Gerber B, Loetscher P, Jones S, Piali L, Clark-Lewis I . Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996; 184(3):963-9. PMC: 2192763. DOI: 10.1084/jem.184.3.963. View

Mach F, Schonbeck U, Sukhova G, Bourcier T, Bonnefoy J, Pober J . Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A. 1997; 94(5):1931-6. PMC: 20020. DOI: 10.1073/pnas.94.5.1931. View

Farber J . Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol. 1997; 61(3):246-57. View

Dansky H, Charlton S, Harper M, Smith J . T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1997; 94(9):4642-6. PMC: 20777. DOI: 10.1073/pnas.94.9.4642. View

10.

Gupta S, Pablo A, Jiang X, Wang N, Tall A, Schindler C . IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest. 1997; 99(11):2752-61. PMC: 508122. DOI: 10.1172/JCI119465. View

11.

Berkhout T, Sarau H, MOORES K, White J, Elshourbagy N, Appelbaum E . Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J Biol Chem. 1997; 272(26):16404-13. DOI: 10.1074/jbc.272.26.16404. View

12.

Libby P, OBrien K . Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol. 1983; 115(2):217-23. DOI: 10.1002/jcp.1041150217. View

13.

Kaplan G, Luster A, Hancock G, COHN Z . The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med. 1987; 166(4):1098-108. PMC: 2188712. DOI: 10.1084/jem.166.4.1098. View

14.

Emeson E, ROBERTSON Jr A . T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol. 1988; 130(2):369-76. PMC: 1880529. View

15.

Gottlieb A, Luster A, Posnett D, Carter D . Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J Exp Med. 1988; 168(3):941-8. PMC: 2189020. DOI: 10.1084/jem.168.3.941. View

16.

Hansson G, Jonasson L, Lojsthed B, Stemme S, Kocher O, Gabbiani G . Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis. 1988; 72(2-3):135-41. DOI: 10.1016/0021-9150(88)90074-3. View

17.

Hansson G, Holm J, Jonasson L . Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989; 135(1):169-75. PMC: 1880219. View

18.

Xu Q, Oberhuber G, Gruschwitz M, Wick G . Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol. 1990; 56(3):344-59. DOI: 10.1016/0090-1229(90)90155-j. View

19.

Wang J, Sica A, Peri G, Walter S, Padura I, Libby P . Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler Thromb. 1991; 11(5):1166-74. DOI: 10.1161/01.atv.11.5.1166. View

20.

Nelken N, Coughlin S, Gordon D, Wilcox J . Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991; 88(4):1121-7. PMC: 295565. DOI: 10.1172/JCI115411. View